Labor Analgesia With Ropivacaine and Clonidine (LA)

This study has been completed.
Sponsor:
Collaborators:
Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Information provided by:
UPECLIN HC FM Botucatu Unesp
ClinicalTrials.gov Identifier:
NCT00626977
First received: February 20, 2008
Last updated: February 28, 2008
Last verified: February 2008
  Purpose

The aim of the present study was to examine, for pain relief during labor, the efficacy of two pharmacological approaches — the 0.125% ropivacaine alone and the 0.0625% ropivacaine added to 75 ug clonidine, both by epidural administration. The effect of the drugs on mother and newborn was also determined.


Condition Intervention
Labor Pain
Drug: ropivacaine
Drug: ropivacaine and clonidine

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial

Resource links provided by NLM:


Further study details as provided by UPECLIN HC FM Botucatu Unesp:

Enrollment: 32
Study Start Date: May 2000
Study Completion Date: December 2001
Estimated Primary Completion Date: May 2000 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
R
R group:15 mL of 0.125% ropivacaine (18.75 mg)
Drug: ropivacaine
15 ml of ropivacaine 0.125% peridural once
RC
RC group:0.0625% ropivacaine (9.375 mg) plus 75 ug clonidine
Drug: ropivacaine and clonidine
15 ml of ropivacaine 0.0625% plus 75 mcg clonidine

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Women having requested epidural analgesia for labor and hers newborns

Criteria

Inclusion Criteria:

  • Singleton healthy
  • Full-term pregnancy
  • American Society of Anesthesiologists physical status I or II

Exclusion Criteria:

  • Patients who had received opioids
  • History of hypersensitivity to local anesthetic or to clonidine
  • Fetus showed signs of possible intrauterine suffering
  • Fetus showed signs of possible neurological deficit
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00626977

Locations
Brazil
College of Medicine of Botucatu
Botucatu, São Paulo, Brazil, 18618970
Sponsors and Collaborators
UPECLIN HC FM Botucatu Unesp
Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Investigators
Principal Investigator: Giane Nakamura, MD PHd College Study of Medicine
  More Information

No publications provided by UPECLIN HC FM Botucatu Unesp

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Clinical Research Ethics Committee of College of Medicine of Botucatu, College of Medicine of Botucatu
ClinicalTrials.gov Identifier: NCT00626977     History of Changes
Other Study ID Numbers: upeclin/HC/FMB-Unesp-07
Study First Received: February 20, 2008
Last Updated: February 28, 2008
Health Authority: Brazil: National Committee of Ethics in Research

Keywords provided by UPECLIN HC FM Botucatu Unesp:
Analgesia
Obstetrical
Anesthesia
Epidural
Newborn
Anesthetics, local
Clonidine
Pregnant women
Infant, newborn

Additional relevant MeSH terms:
Labor Pain
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Clonidine
Ropivacaine
Antihypertensive Agents
Cardiovascular Agents
Therapeutic Uses
Pharmacologic Actions
Sympatholytics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Analgesics
Sensory System Agents
Central Nervous System Agents
Anesthetics, Local
Anesthetics
Central Nervous System Depressants

ClinicalTrials.gov processed this record on July 26, 2014